Suchen
180 Life Sciences Corp
ATNFWZur Watchlist hinzufügen
0.430USD
0.0000.00%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
0.00Marktkapitalisierung
--KGV TTM
mehr Informationen über 180 Life Sciences Corp Unternehmen
180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.
180 Life Sciences Corp Informationen
BörsenkürzelATNFW
Name des Unternehmens180 Life Sciences Corp
IPO-datumJun 07, 2017
CEOMr. Blair Jordan
Anzahl der mitarbeiter- -
WertpapierartCompany Warrant
Geschäftsjahresende- -
Addresse3000 El Camino Real
StadtPALO ALTO
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl94306
Telefon16505070669
Websitehttps://180lifesciences.com/
BörsenkürzelATNFW
IPO-datumJun 07, 2017
CEOMr. Blair Jordan
Führungskräfte von 180 Life Sciences Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
--
--
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
--
--
Mr. Jason G. New
Mr. Jason G. New
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John T. Saunders
Mr. John T. Saunders
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
Chief Financial Officer, (Principal Accounting/Financial) and Secretary
--
--
Ms. Crystal Heter
Ms. Crystal Heter
Independent Director
Independent Director
--
--
Mr. Andrew Suckling
Mr. Andrew Suckling
Independent Director
Independent Director
--
--
Mr. Jason Assad
Mr. Jason Assad
Investor Relations
Investor Relations
--
--
Mr. McAndrew Rudisill
Mr. McAndrew Rudisill
Chairman, Chief Executive Officer
Chairman, Chief Executive Officer
--
--
Mr. Ryan Lewis Smith
Mr. Ryan Lewis Smith
Lead Independent Director
Lead Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von 180 Life Sciences Corp?
Die fünf größten Anteilseigner von 180 Life Sciences Corp sind: Mr. John T. Saunders